Treatment and management of the rare disorder von Hippel-Lindau (VHL) disease is complicated due to the development of benign and malignant tumors and cysts in numerous organs/systems. Given the progressive nature of the disease and the development of disease manifestations over time, management often involves local control requiring a multidisciplinary approach. However, recently developed systemic therapies targeting the root cause of VHL disease provide an opportunity for effective management across numerous disease manifestations. Through this interactive Clinical Case Challenge, follow a real-world patient case, get instant feedback on answers to clinically relevant questions, and access downloadable evidence and relevant clinical practice tips. You can also see how you stack up against the knowledge of fellow healthcare providers!
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/advancing-diagnosis-evidence-based-care-von-hippel-lindau-disease-micro
- Start Date: 2024-02-29 06:00:00
- End Date: 2024-02-29 06:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - MOC Credit Details: ABIM - 0.25 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Merck (Any division) - Amount: 33166.67 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Internal Medicine